People · Operator

Jerome John Lyden

Named in public records as an officer, director or promoter · active 2022–2022 · Healthtech

1
Companies
2
Filings
$38.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Jet Health, Inc.HealthtechSeries B$38.9M$29.3M2022
Operator network

Jerome John Lyden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David Tamburri · 10 companies · 1 sharedDavid TamburriThomas Flynn · 4 companies · 1 sharedThomas FlynnThomas J. Flynn · 3 companies · 1 sharedThomas J. FlynnAlicia J. Price · 1 companies · 1 sharedAlicia J. PriceDavid J. Tamburri · 1 companies · 1 sharedDavid J. TamburriJames D. Glynn · 1 companies · 1 sharedJames D. GlynnJames Glynn · 1 companies · 1 sharedJames GlynnJames M. Douthitt · 1 companies · 1 sharedJames M. DouthittJim J. Douthitt · 1 companies · 1 sharedJim J. DouthittListon J. Thomas · 1 companies · 1 sharedListon J. ThomasMatthew J. Crooks · 1 companies · 1 sharedMatthew J. CrooksStacie J. Bratcher · 1 companies · 1 sharedStacie J. BratcherStephen Griggs · 1 companies · 1 sharedStephen GriggsStephen J. Griggs · 1 companies · 1 sharedStephen J. GriggsJet Health, Inc. · $38.9M raisedJet Health, Inc.Jerome John LydenJL
Jerome John Lyden Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jerome John Lyden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David Tamburri110
Thomas Flynn14
Thomas J. Flynn13
Stephen Griggs11
James M. Douthitt11
David J. Tamburri11
James D. Glynn11
Stephen J. Griggs11
Stacie J. Bratcher11
Jim J. Douthitt11
Alicia J. Price11
Matthew J. Crooks11
James Glynn11
Liston J. Thomas11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.